Literature DB >> 19878831

Changes in drug susceptibility and the quinolone-resistance determining region of Staphylococcus epidermidis after administration of fluoroquinolones.

Masaru Miyanaga1, Ryohei Nejima, Takashi Miyai, Kazunori Miyata, Yuichi Ohashi, Yoshitsugu Inoue, Masahiro Toyokawa, Seishi Asari.   

Abstract

PURPOSE: To evaluate the correlation between changes in the susceptibility of bacteria and mutations in the quinolone-resistance determining region (QRDR) after 3 weeks of continuous fluoroquinolone instillation.
SETTING: Miyata Eye Hospital, Miyazaki, Japan.
METHODS: In this prospective randomized study, gatifloxacin 0.3% eyedrops or levofloxacin 0.5% eyedrops were administered for 1 week before cataract surgery and for 2 weeks after surgery. Samples were collected from the conjunctival sac before instillation of the antibiotic agent and 14 days after surgery. Susceptibility to the fluoroquinolones and gene mutations in the QRDR of the isolated Staphylococcus epidermidis were analyzed.
RESULTS: The detection rate of S. epidermidis was 27% in the gatifloxacin group (n=79 eyes) and 21% in the levofloxacin group (n=73 eyes) before instillation of the antibiotic and 6% and 19%, respectively, 14 days postoperatively. The susceptibility rates of S. epidermidis strains to levofloxacin were statistically significantly lower after instillation than before antibiotic instillation, and the number of gene mutations in the QRDR was statistically significantly higher after instillation. There was no difference in the gatifloxacin group between before and after antibiotic instillation. In the 9 eyes in which S. epidermidis was detected in samples taken before and after antibiotic instillation, most strains were genetically different from each other between the 2 time points.
CONCLUSIONS: Three-week continuous instillation of levofloxacin affected the indigenous bacterial flora in the conjunctival sac, suggesting possible induction of microbial substitution to fluoroquinolone-resistant S. epidermidis. However, there was no change with gatifloxacin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19878831     DOI: 10.1016/j.jcrs.2009.05.049

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  6 in total

1.  Emerging 8-methoxyfluoroquinolone resistance among methicillin-susceptible Staphylococcus epidermidis isolates recovered from patients with endophthalmitis.

Authors:  Paulo J M Bispo; Eduardo C Alfonso; Harry W Flynn; Darlene Miller
Journal:  J Clin Microbiol       Date:  2013-07-03       Impact factor: 5.948

Review 2.  Ocular surface flora and prophylactic antibiotics for cataract surgery in the age of antimicrobial resistance.

Authors:  Takuya Iwasaki; Ryohei Nejima; Kazunori Miyata
Journal:  Jpn J Ophthalmol       Date:  2022-01-10       Impact factor: 2.447

3.  Clinical utility of antimicrobial susceptibility measurement plate covering formulated concentrations of various ophthalmic antimicrobial drugs.

Authors:  Norihiko Tou; Ryohei Nejima; Yoshifumi Ikeda; Yuichi Hori; Kaoru Araki-Sasaki; Kazunori Miyata; Yoshitsugu Inoue; Akihiko Tawara
Journal:  Clin Ophthalmol       Date:  2016-11-09

4.  Conjunctival colonisation and antibiotic resistance of coagulase-negative Staphylococcus after cataract surgery: a 6-month longitudinal study at a medical centre in Taiwan.

Authors:  Eugene Yu-Chuan Kang; Chiun-Ho Hou; Yhu-Chering Huang; Ching-Hsi Hsiao
Journal:  BMJ Open       Date:  2019-06-18       Impact factor: 2.692

5.  Prevalence of drug resistance and culture-positive rate among microorganisms isolated from patients with ocular infections over a 4-year period.

Authors:  Yusuke Shimizu; Hiroshi Toshida; Rio Honda; Asaki Matsui; Toshihiko Ohta; Yousuke Asada; Akira Murakami
Journal:  Clin Ophthalmol       Date:  2013-04-09

6.  Fluoroquinolone resistance of Staphylococcus epidermidis isolated from healthy conjunctiva and analysis of their mutations in quinolone-resistance determining region.

Authors:  Jung Youb Kang; Woonhyoung Lee; Gwang Myeong Noh; Bo Hyun Jeong; Indal Park; Sang Joon Lee
Journal:  Antimicrob Resist Infect Control       Date:  2020-11-04       Impact factor: 4.887

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.